Agilix

Agilix Corporation is a leading developer of next generation functional genomics and proteomics platform technologies.

Agilix Corporation is a leading developer of next generation functional genomics and proteomics platform technologies for the systematic discovery and analysis of genes, their protein products and related biological functions. Our technologies and services help reduce the risk, cost and time to market for new pharmaceutical, biotechnology and agricultural products. Founded in 1999, Agilix Corporation licensed numerous technologies from Yale University. Today, Agilix offers its partners and customers access to unique technologies and services that enable users to globally interrogate the expressed genes and proteins of biologically diverse organisms to ultimately increase the speed and cost-effectiveness of target discovery and new product development. Agilix's GenCompassTM is the first universal whole genome microarray platform that globally profiles the expressed genes of any organism. Agilix provides access to GenCompass through Agilix's collaborative research services. The Company's i-PROTTM Labeling technology is the most versatile protein labeling technology available, allowing multiplex protein profiling, in vivo labeling and high throughput assay development. Agilix provides access to the i-PROT Labeling technology through strategic partnerships.